1. ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML. (20th July 2017) Authors: Tiribelli, Mario; Geromin, Antonella; Cavallin, Margherita; Di Giusto, Sara; Simeone, Erica; Fanin, Renato; Damiani, Daniela Journal: European journal of haematology Issue: Volume 99:Number 3(2017) Page Start: 269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ABCG2 overexpression and deoxyadenosine analogue activity in acute myeloid leukemia. Issue 24 (20th October 2017) Authors: Tiribelli, Mario; Michelutti, Angela; Fanin, Renato; Damiani, Daniela Journal: Cancer Issue: Volume 123:Issue 24(2017) Page Start: 4934 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome. Issue 9 (22nd July 2015) Authors: Damiani, Daniela; Tiribelli, Mario; Geromin, Antonella; Michelutti, Angela; Cavallin, Margherita; Sperotto, Alessandra; Fanin, Renato Journal: American journal of hematology Issue: Volume 90:Issue 9(2015:Sep.) Page Start: 784 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients. Issue 10 (23rd July 2013) Authors: Damiani, Daniela; Tiribelli, Mario; Franzoni, Alessandra; Michelutti, Angela; Fabbro, Dora; Cavallin, Margherita; Toffoletti, Eleonora; Simeone, Erica; Fanin, Renato; Damante, Giuseppe Journal: American journal of hematology Issue: Volume 88:Issue 10(2013:Oct.) Page Start: 848 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. BCR:ABL1 levels at first month after TKI discontinuation predict subsequent maintenance of treatment‐free remission: A study from the "GRUPPO TRIVENETO LMC". (8th October 2022) Authors: Di Giusto, Sara; Toffoletti, Eleonora; Bonifacio, Massimiliano; Binotto, Gianni; Miggiano, Maria Cristina; Calistri, Elisabetta; Stulle, Manuela; Ermacora, Anna; Stella, Rossella; Scaffidi, Luigi; D'Amore, Fabio; Scotton, Giorgia; Griguolo, Davide; De Matteis, Giovanna; Bertorelle, Roberta; Kramp... Journal: Cancer medicine Issue: Volume 12:Number 3(2023) Page Start: 3180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Haploidentical transplant after failure of a first allogeneic transplant: A long and winding road. (15th March 2021) Authors: Tiribelli, Mario; Sperotto, Alessandra; Patriarca, Francesca; Damiani, Daniela; Fanin, Renato Journal: European journal of haematology Issue: Volume 106:Number 6(2021) Page Start: 871 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients. (July 2017) Authors: Tiribelli, Mario; Raspadori, Donatella; Geromin, Antonella; Cavallin, Margherita; Sirianni, Santina; Simeone, Erica; Bocchia, Monica; Fanin, Renato; Damiani, Daniela Journal: Leukemia research Issue: Volume 58(2017:Jul.) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of fludarabine‐based induction therapy on outcome of FLT3−/NPM1+ cytogenetically normal acute myeloid leukemia. Issue 4 (13th February 2017) Authors: Tiribelli, Mario; Geromin, Antonella; Damiani, Daniela Journal: American journal of hematology Issue: Volume 92:Issue 4(2017:Apr.) Page Start: E45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of fludarabine‐based induction therapy on outcome of FLT3−/NPM1+ cytogenetically normal acute myeloid leukemia. Issue 4 (13th February 2017) Authors: Tiribelli, Mario; Geromin, Antonella; Damiani, Daniela Journal: American journal of hematology Issue: Volume 92:Issue 4(2017:Apr.) Page Start: E45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Optimal timing of molecular monitoring after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia. (13th December 2022) Authors: Tiribelli, Mario; Toffoletti, Eleonora; Di Giusto, Sara; Fanin, Renato; Damiani, Daniela Journal: European journal of haematology Issue: Volume 110:Number 3(2023) Page Start: 330 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗